欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	NL/H/4281/003
药品名称	Everolimus Sandoz 10 mg, tabletten
活性成分	everolimus 10.0 mg
剂型	Tablet
上市许可持有人	Sandoz B.V. Veluwezoom 22 1327 AH Netherlands
参考成员国 - 产品名称	Netherlands (NL) Everolimus Sandoz 10 mg, tabletten
互认成员国 - 产品名称	Denmark (DK) Everolimus "Sandoz" Belgium (BE) Everolimus Sandoz 10 mg tabletten United Kingdom (Northern Ireland) (XI) France (FR) Greece (GR) Sweden (SE) Norway (NO) Everolimus Sandoz Finland (FI) Hungary (HU) EVEROLIMUS SANDOZ 10 mg tabletta Bulgaria (BG) Everolimus Sandoz Czechia (CZ) Everolimus Sandoz Slovakia (SK) Everolimus Sandoz 10 mg
许可日期	2019/01/07
最近更新日期	2024/03/22
药物ATC编码	L01XE10 everolimus
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final SPC \| Final SmPCDate of last change:2022/12/23 Final PL \| EverilimusDate of last change:2022/10/10 Final Product Information \| 1.3.1 spc-label-pl - common-outer - 5,722-trackedDate of last change:2021/02/15 Final Product Information \| 1.3.1 spc-label-pl - common-pl - 11,976-cleanDate of last change:2021/02/15 Final Product Information \| 1.3.1 spc-label-pl - common-outer - 5,722-cleanDate of last change:2021/02/15 Final Product Information \| 1.3.1 spc-label-pl - common-spc - 11,470-cleanDate of last change:2021/02/15 Final Product Information \| 1.3.1 spc-label-pl - common-pl - 11,976-trackedDate of last change:2021/02/15 Final Product Information \| 1.3.1 spc-label-pl - common-spc - 11,470-trackedDate of last change:2021/02/15
市场状态	Positive